Literature DB >> 21768511

When carbapenem-hydrolyzing beta-lactamase Kpc meets Escherichia coli ST131 in France.

Thierry Naas, Gaelle Cuzon, Olivier Gaillot, René Courcol, Patrice Nordmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21768511      PMCID： PMC3186948          DOI： 10.1128/AAC.00719-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  13 in total

1.  Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-beta-lactamase VIM-1.

Authors:  Vivi Miriagou; Eva Tzelepi; Dimitra Gianneli; Leonidas S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

2.  First case of New Delhi metallo-beta-lactamase 1-producing Escherichia coli infection in Japan.

Authors:  Shingo Chihara; Katsuko Okuzumi; Yoshitaka Yamamoto; Shinji Oikawa; Akira Hishinuma
Journal:  Clin Infect Dis       Date:  2011-01-01       Impact factor: 9.079

3.  Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel.

Authors:  Shiri Navon-Venezia; Inna Chmelnitsky; Azita Leavitt; Mitchell J Schwaber; David Schwartz; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 4.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.

Authors:  Johann D D Pitout; Kevin B Laupland
Journal:  Lancet Infect Dis       Date:  2008-03       Impact factor: 25.071

5.  Spread of OXA-48-encoding plasmid in Turkey and beyond.

Authors:  Amélie Carrër; Laurent Poirel; Mesut Yilmaz; Ozay Arikan Akan; Cilli Feriha; Gaëlle Cuzon; Ghassan Matar; Patrick Honderlick; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

6.  Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia.

Authors:  Anton Y Peleg; Clare Franklin; Jan M Bell; Denis W Spelman
Journal:  Clin Infect Dis       Date:  2005-10-31       Impact factor: 9.079

Review 7.  The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.

Authors:  Patrice Nordmann; Gaelle Cuzon; Thierry Naas
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

8.  Emergence of carbapenem-resistant Escherichia coli in Taiwan: resistance due to combined CMY-2 production and porin deficiency.

Authors:  J H Chia; L K Siu; L H Su; H S Lin; A J Kuo; M H Lee; T L Wu
Journal:  J Chemother       Date:  2009-12       Impact factor: 1.714

9.  Emergence of imipenem resistance in clinical Escherichia coli during therapy.

Authors:  Jesús Oteo; Alberto Delgado-Iribarren; Dolores Vega; Verónica Bautista; María Cruz Rodríguez; María Velasco; José María Saavedra; María Pérez-Vázquez; Silvia García-Cobos; Luis Martínez-Martínez; José Campos
Journal:  Int J Antimicrob Agents       Date:  2008-09-04       Impact factor: 5.283

10.  Sex and virulence in Escherichia coli: an evolutionary perspective.

Authors:  Thierry Wirth; Daniel Falush; Ruiting Lan; Frances Colles; Patience Mensa; Lothar H Wieler; Helge Karch; Peter R Reeves; Martin C J Maiden; Howard Ochman; Mark Achtman
Journal:  Mol Microbiol       Date:  2006-06       Impact factor: 3.501
View more
  23 in total

1.  Detection of OXA-48 carbapenemase in the pandemic clone Escherichia coli O25b:H4-ST131 in the course of investigation of an outbreak of OXA-48-producing Klebsiella pneumoniae.

Authors:  Dearbháile Morris; Edel McGarry; Meaghan Cotter; Virginie Passet; Maureen Lynch; Catherine Ludden; Margaret M Hannan; Sylvain Brisse; Martin Cormican
Journal:  Antimicrob Agents Chemother       Date:  2012-05-07       Impact factor: 5.191

2.  Environmental KPC-producing Escherichia coli isolates in Portugal.

Authors:  Laurent Poirel; Ana Barbosa-Vasconcelos; Roméo Rocha Simões; Paulo Martins Da Costa; Winchygn Liu; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2011-12-27       Impact factor: 5.191

Review 3.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

4.  Molecular epidemiology of KPC-producing Escherichia coli: occurrence of ST131-fimH30 subclone harboring pKpQIL-like IncFIIk plasmid.

Authors:  Jessica A O'Hara; Fupin Hu; Chulsoo Ahn; Jeremy Nelson; Jesabel I Rivera; Anthony W Pasculle; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2014-05-12       Impact factor: 5.191

5.  Emergence of KPC-2-producing Escherichia coli isolates in an urban river in Harbin, China.

Authors:  Guofeng Xu; Yue Jiang; Wei An; Hongdong Wang; Xiuying Zhang
Journal:  World J Microbiol Biotechnol       Date:  2015-07-07       Impact factor: 3.312

Review 6.  The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.

Authors:  Amy J Mathers; Gisele Peirano; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

7.  Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections.

Authors:  Sheila Adams-Sapper; Binh An Diep; Francoise Perdreau-Remington; Lee W Riley
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

8.  Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China.

Authors:  Jia Chang Cai; Rong Zhang; Yan Yan Hu; Hong Wei Zhou; Gong-Xiang Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

9.  Dominance of IMP-4-producing enterobacter cloacae among carbapenemase-producing Enterobacteriaceae in Australia.

Authors:  Hanna E Sidjabat; Nicola Townell; Graeme R Nimmo; Narelle M George; Jennifer Robson; Renu Vohra; Louise Davis; Claire Heney; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

Review 10.  Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.

Authors:  L Silvia Munoz-Price; Laurent Poirel; Robert A Bonomo; Mitchell J Schwaber; George L Daikos; Martin Cormican; Giuseppe Cornaglia; Javier Garau; Marek Gniadkowski; Mary K Hayden; Karthikeyan Kumarasamy; David M Livermore; Juan J Maya; Patrice Nordmann; Jean B Patel; David L Paterson; Johann Pitout; Maria Virginia Villegas; Hui Wang; Neil Woodford; John P Quinn
Journal:  Lancet Infect Dis       Date:  2013-09       Impact factor: 25.071
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.